The Woodlands, TX, United States of America

Greg Fontenot

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Repros Therapeutics Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Greg Fontenot. Retrieved from https://idiyas.com/inventor/greg-fontenot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Greg Fontenot

Introduction: Greg Fontenot, based in The Woodlands, Texas, has made significant strides in the field of pharmaceutical innovation. With a total of two patents to his name, he is recognized for his contributions towards improving cancer therapy and enhancing bone health through novel compounds.

Latest Patents: Fontenot's most recent inventions focus on trans-clomiphene, which has potential applications in treating cancer and bone disorders. The first patent details a method for administering compositions that include trans-clomiphene, a selective estrogen receptor modulator, aimed at treating cancer and associated diseases. This innovation not only offers a new therapeutic approach but also provides methods for reducing IGF-1 levels in patients in need. His second patent explores the use of trans-clomiphene and its analogs for increasing bone mineral density. This invention outlines methods for inhibiting bone resorption and turnover, thereby preventing or treating bone-related disorders in individuals.

Career Highlights: Greg Fontenot is affiliated with Repros Therapeutics Inc., where he continues his work on groundbreaking pharmaceuticals. His contribution to the field is underscored by his innovative approaches, which seek to address critical health challenges faced by patients worldwide.

Collaborations: Collaborating with experts such as Joseph S. Podolski and Ronald D. Wiehle, Fontenot has engaged in impactful research that advances therapeutic options available to patients. The collective efforts of these professionals reflect a commitment to discovering and developing effective medical solutions.

Conclusion: Greg Fontenot's work exemplifies the spirit of innovation in the pharmaceutical industry. Through his patents and collaborations, he contributes significantly to advancements in cancer therapy and bone health, underscoring the importance of continued research and development in medical sciences. His achievements highlight the role of inventors in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…